A carregar...

Whole Chromosome alterations predict survival in high risk neuroblastoma without MYCN amplification

PURPOSE: Patients with stage 4 neuroblastoma over the age of 500 days without MYCN amplification have a survival rate of less than 30% and there are currently no reliable means of predicting which of these patients will survive or succumb from the disease. The goal of this study is to develop a DNA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bilke, Sven, Chen, Qing-Rong, Wei, Jun S., Khan, Javed
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2535913/
https://ncbi.nlm.nih.gov/pubmed/18765546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-4461
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!